Asciminib
Common Brand Names:
Scemblix
Drug Class
BCR-ABL tyrosine kinase inhibitors
Animal-free Options?
No. Contact Pill Clarity for more information.
Indication
Treatment of adult patients with: Newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). This indication is approved under accelerated approval based on major molecular response rate [see Clinical Studies (14.1)]. Continued approval for this indication may be contingent upon verification of clinical benefit in a confirmatory trial(s). Previously treated Ph+ CML in CP. Ph+ CML in CP with the T315I mutation.
Why you need to contact us:
Formulations are subject to change, so it's important to consult your healthcare provider or the manufacturer. Our Pill Clarity pharmacists are here to assist. Please note that our product information is general and not a substitute for professional medical advice. Pill Clarity does not assess safety or efficacy of medications.
*The product and/or information provided on Pill Clarity is of a general nature and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. We do not lab test the products to confirm that they are free from animal ingredients, and it is possible that the formulation and ingredients could have changed. Pill Clarity does not assess safety or efficacy of medications. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or product.